Tolerability of short-term, high-dose formoterol in healthy volunteers and patients with asthma
- 1 November 2003
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 25 (11) , 2635-2646
- https://doi.org/10.1016/s0149-2918(03)80325-9
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Safety of formoterol Turbuhaler® at cumulative dose of 90 µg in patients with acute bronchial obstructionEuropean Respiratory Journal, 2001
- Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severityJournal of Allergy and Clinical Immunology, 1999
- FormoterolDrugs, 1998
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaNew England Journal of Medicine, 1997
- Clinical Experience over Five Years of Daily Therapy with Formoterol in Patients with Bronchial AsthmaClinical Drug Investigation, 1997
- Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study InvestigatorsThorax, 1997
- Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of actionEuropean Respiratory Journal, 1996
- Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma.Thorax, 1993
- Rapid Onset of Action of Inhaled Formoterol in Asthmatic PatientsChest, 1992
- The Effect of Maximal Doses of Formoterol and Salbutamol from a Metered Dose Inhaler on Pulse Rates, ECG, and Serum Potassium ConcentrationsChest, 1991